KRAS and neoplasm: MGMT-unmethylated (MGMT-U) and MGMT-M subgroups showed no differences by gender, age, tumor differentiation, CIMP, MSI and KRAS mutation status or the receipt of chemotherapy/radiotherapy between the two groups (Table 1).